Early BCG-Denmark and Neonatal Mortality Among Infants Weighing <2500 g: A Randomized Controlled Trial

BACKGROUND: BCG vaccine may reduce overall mortality by increasing resistance to nontuberculosis infections. In 2 randomized trials in Guinea-Bissau of early BCG-Denmark (Statens Serum Institut) given to low-weight (LW) neonates (<2500 g at inclusion) to reduce infant mortality rates, we observed...

Descripción completa

Detalles Bibliográficos
Autores principales: Biering-Sørensen, Sofie, Aaby, Peter, Lund, Najaaraq, Monteiro, Ivan, Jensen, Kristoffer Jarlov, Eriksen, Helle Brander, Schaltz-Buchholzer, Frederik, Jørgensen, Anne Sofie Pinstrup, Rodrigues, Amabelia, Fisker, Ane Bærent, Benn, Christine Stabell
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2017
Materias:
Articles and Commentaries
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5849087/
https://www.ncbi.nlm.nih.gov/pubmed/29579158
http://dx.doi.org/10.1093/cid/cix525

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5849087/
https://www.ncbi.nlm.nih.gov/pubmed/29579158
http://dx.doi.org/10.1093/cid/cix525

Ejemplares similares